West Pharma (WST) Reports Q3 EPS of $0.44

West Pharma (NYSE: WST) reported Q3 EPS of $0.44, versus $0.44 reported last year. Revenue for the quarter came in at $344.5 million, versus $355.9 million reported last year.

West Pharma sees FY2015 EPS of $1.79-$1.84.

For earnings history and earnings-related data on West Pharma (WST) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Walmart shares fall despite earnings beat